Preoperative fasting time in children

S Adeel1, M Arain, M Healy

  • 1Department of Anaesthesia, Our Lady's Children's Hospital, Crumlin, Dublin. drshahidadeel@hotmail.com

Irish Medical Journal
|June 26, 2009
PubMed

Insights

Most Irish anesthetists follow American Society of Anaesthesiologists guidelines for preoperative fasting in children. However, opinions differ on fasting durations for formula and breast milk, highlighting a need for clearer communication.

Area of Science:

  • Anesthesiology
  • Pediatric Surgery

Background:

  • Preoperative fasting is crucial to prevent aspiration and manage dehydration.
  • The American Society of Anaesthesiologists (ASA) provides guidelines for pediatric preoperative fasting.

Purpose of the Study:

  • To assess current adherence to ASA preoperative fasting guidelines by anesthesia registrars in Ireland.
  • To identify variations in fasting practices for pediatric elective surgery.

Main Methods:

  • A postal survey was conducted among specialist registrars in anesthesia in Ireland.
  • A questionnaire addressed fasting durations for clear fluids, solids, formula, and breast milk.
  • 60 out of 90 (67%) questionnaires were returned and analyzed.

Main Results:

  • Most respondents adhere to ASA guidelines for clear fluids and solids.
  • Significant variation exists in the recommended fasting times for formula and breast milk.
  • Current practices show inconsistencies regarding specific aspects of pediatric preoperative fasting.

Conclusions:

  • Greater awareness and collaboration are needed among anesthesiologists, nurses, and surgeons.
  • Fasting instructions should be standardized to align with ASA guidelines.
  • Ensuring patient and parental understanding of fasting directives is essential.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...